Project organization: Pfizer, Inc.

Protein A Chromatography Multi-scale Data Driven/Mechanistic Modeling (Phase 2)

Next-generation Factory Business & Data Mapping

Commercial Deployment of Integrated PAT Technologies to Enable Continuous Upstream Production of Glycosylated Monoclonal Antibodies

Creating a Neurodiverse Talent Pipeline for the Biomanufacturing Industry

Next Gen High Level Design of Facility Layout

Surrogate ADCs for Process Development and Quality Assessment

Modernizing clearance and quantification of host-cell proteins in mAb manufacture

Cell Culture Glycosylation Multi-scale Data Driven Mechanistic Modeling (Phase 2)

Time-Gated Raman spectroscopy to improve chemical sensitivity for in-situ bioreactor monitoring

N-mAb

PI – DNP Development & Adoption

PI – Rapid Micro: novel methods and control strategy